Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

ABSTRACT: Transcription factors play a critical regulatory role in the occurrence and development of malignant tumors. MAZ (MYC-Associated Zinc finger protein), as an important transcriptional ...

A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...

For thousands of Kenyan men who survive prostate cancer each year, one of the most difficult and less talked about struggles is how the treatments often leave disruptions to their sexual health: ...

Riitvek Baddireddi, an Oregon State University junior, is looking forward to time off before the new term starts Jan. 5. During his break, Baddireddi, 20, will be recharging with friends, playing ...

Medicus Pharma is advancing Teverelix, a recently acquired, clinical stage asset, designed to address limitations of current hormone therapies for prostate cancer and benign prostatic hyperplasia (BPH ...

Men with advanced prostate cancer have been offered fresh hope thanks to a “promising” new drug combination. It could significantly delay the progression of a deadly form of the disease in patients ...